Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Clasificación en acciones #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Precio por acción
$0.2219522
Última sincronización: 2025-09-11
Capitalización bursátil
$1.10B
Cambio (1 día)
0.04%
Cambio (1 año)
0.17%
País
CN
Comercio Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Ganancias de Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Ganancias en Sep 2024 TTM: $-246.31M
Secondo gli ultimi rapporti finanziari di Hubei Biocause Pharmaceutical Co., Ltd., gli utili attuali della società sono $-246.31M. Nel 2022, la società ha registrato un utile di $32.59M, una disminución en comparación con agli utili del 2021, che erano di $53.98M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Hubei Biocause Pharmaceutical Co., Ltd. desde 2000 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-246.31M -6.66%
2023 $-263.90M -909.84%
2022 $32.59M -39.64%
2021 $53.98M -75.67%
2020 $221.88M -57.48%
2019 $521.80M 36.14%
2018 $383.27M -8.47%
2017 $418.73M -15.31%
2016 $494.40M 859.98%
2015 $51.50M 192.79%
2014 $17.59M -182.99%
2013 $-21.20M -981.31%
2012 $2.40M -112.99%
2011 $-18.51M -493.30%
2010 $4.71M -45.74%
2009 $8.67M 709.23%
2008 $1.07M -93.04%
2007 $15.40M 107.42%
2006 $7.42M 610.69%
2005 $1.04M 72.62%
2004 $605.05K -110.58%
2003 $-5.72M -392.76%
2002 $1.95M -72.00%
2001 $6.97M 18.03%
2000 $5.91M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$43.81B -17,885.82%
CN
$9.54B -3,973.90%
HK
- -
CA
- -
TW
- -
US